Effect of bariatric surgery on weight loss, inflammation, Iron metabolism, and lipid profile

Scandinavian Journal of Surgery

Volumn 103, Issue 1, 2014, Pages 21-25

  Santos, J ^a,b   Salgado, P ^c   Santos, C ^d   Mendes, P ^a   Saavedra, J ^a   Baldaque, P ^a   Monteiro, L ^a   Costa, Elísio ^d,e  

^a Hospital da Prelada   (Portugal)

^b CATHOLIC UNIVERSITY OF PORTUGAL   (Portugal)

^c Instituto Politécnico de Saúde do Norte   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

Adiposity; Erythropoiesis; Gastric banding; Inflammation; Lipid profile; Obesity

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; IRON; TRIACYLGLYCEROL;

ADULT; BLOOD; BLOOD CELL COUNT; BODY MASS; CLINICAL TRIAL; COMPLICATION; ERYTHROPOIESIS; FEMALE; FOLLOW UP; GASTROPLASTY; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; OBESITY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; BIOLOGICAL MARKERS; BLOOD CELL COUNT; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; ERYTHROPOIESIS; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HUMANS; INFLAMMATION; IRON; MALE; MIDDLE AGED; OBESITY; TREATMENT OUTCOME; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84902689052     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1457496913490467     Document Type: Article

References (26)

1. Duncan S, Duncan EK, Fernandes RA, et al: Modifiable risk factors for overweight and obesity in children and adolescents from Sao Paulo, Brazil. BMC Public Health 2011;11:585.
2. Ko GT, Chan JC: Burden of obesity-Lessons learnt from Hong Kong Chinese. Obes Rev 2008;9(Suppl. 1):35-40.
3. Alexander CM, Landsman PB, Grundy SM: The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab 2008;10(3):246-250.
4. Rondinone CM, Adipocyte-derived hormones, cytokines, and mediators. Endocrine 2006;29(1):81-90.
5. Folsom AR, Pankow JS, Tracy RP, et al: Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001;88(2):112-117.
6. Blake GJ, Ridker PM: Novel clinical markers of vascular wall inflammation. Circ Res 2001;89(9):763-771.
7. Rosenthal RJ, Szomstein S, Kennedy CI, et al: Laparoscopic surgery for morbid obesity: 1,001 consecutive bariatric operations performed at The Bariatric Institute, Cleveland Clinic Florida. Obes Surg 2006;16(2):119-124.
8. Weiner R, Blanco-Engert R, Weiner S, et al: Outcome after laparoscopic adjustable gastric banding-8 years experience. Obes Surg 2003;13(3):427-434.
9. Himpens J, Cadière GB, Bazi M, et al: Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg 2011;146(7):802-807.
10. Pilone V, Mozzi E, Schettino AM, et al; Italian Group for Lap- Band: Improvement in health-related quality of life in first year after laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2012;8(3):260-268.
11. Dixon JB, Dixon ME, O'Brien PE: Quality of life after lap-band placement: Influence of time, weight loss, and comorbidities. Obes Res 2001;9:713-721.
12. Rutten SJ, de Goederen-van der Meij S, Pierik RG, et al: Changes in quality of life after balloon treatment followed by gastric banding in severely obese patients-The use of two different quality of life questionnaires. Obes Surg 2009;19(8): 1124-1131.
13. Mamplekou E, Komesidou V, Bissias CH: Psychological condition and quality of life in patients with morbid obesity before and after surgical weight loss. Obes Surg 2005;15(8):1177-1184.
14. Mathus-Vliegen EM, Wit LT: Health-related quality of life after gastric banding. Br J Surg 2007;94:457-465.
15. Dixon JB, O'Brien PE: Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002;184(6B):51-54.
16. Korenkov M, Shah S, Sauerland S, et al: Impact of laparoscopic adjustable gastric banding on obesity co-morbidities in the medium and long term. Obes Surg 2007;17(5):679-683.
17. Hillman RS, Ault KA: Clinical approach to anemia. In: Hillman RS, Ault KA (eds) Hematology in clinical practice 3rd ed. McGraw-Hill, New York, 2002, pp. 12-26.
18. Wood IS, Heredia FP, Wang B, et al: Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc 2009;68(4): 370-377.
19. Ramalho R, Guimarães C, Gil C, et al: Morbid obesity and inflammation: A prospective study after adjustable gastric banding surgery. Obes Surg 2009;19(7):915-920.
20. Wisse BE: The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004;15:2792-2800.
21. Viardot A, Lord RV, Samaras K: The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes. J Clin Endocrinol Metab 2010;95(6):2845-2850.
22. Merhi ZO, Durkin HG, Feldman J, et al: Effect of bariatric surgery on peripheral blood lymphocyte subsets in women. Surg Obes Relat Dis 2009;5(2):165-171.
23. Nemeth E, Preza GC, Jun CL, et al: The N-terminus of hepcidin is essential for its interaction with ferroportin: Structure-function study. Blood 2006;107:328-333.
24. Nicolas G, Viatte L, Bennoun M, et al: Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 2002;29:327-353.
25. Tussing-Humphreys LM, Nemeth E, Fantuzzi G, et al: Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Obesity 2010;18(10): 2010-2016.
26. Illán-Gómez F, Gonzálvez-Ortega M, Orea-Soler I, et al: Obesity and inflammation: Change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg 2012;22(6):950-955.